FDA Emergency Use Power Could Expand Under Bill Moving To House Floor
Executive Summary
FDA could get the power to issue an Emergency Use Authorization before a pandemic or other emergency, according to legislation reauthorizing the Pandemic and All-Hazards Preparedness Act.
You may also be interested in...
Bioterror “Strategic Investor” Initiative Must Be Resolved As House, Senate Pass Dueling Bills
House- and Senate-passed bills reauthorizing the 2006 Pandemic and All-Hazards Preparedness Act are similar in many respects in their efforts to accelerate medical countermeasure development. However, the House bill lacks a Senate provision that would allow HHS to contract with a non-profit entity to invest in companies developing countermeasures.
Biosimilar User Fee Negotiations Under Way; Timetable Compressed
FDA has started biosimilar user fee negotiations with industry, although it does not appear the room is overcrowded with participants.
PDUFA V: Emerging Sponsor Communication Issue Resolved And Expanded
FDA and industry plan to create more staff to help deal with simple and clarifying questions from emerging and experienced sponsors during the application review process as part of PDUFA V.